http://orcid.org/0000-0003-4241-5135
Citations (61)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Giacomo Sferruzza, Luca Bosco, Yuri Matteo Falzone, Tommaso Russo, Teuta Domi, Angelo Quattrini, Massimo Filippi & Nilo Riva. (2022) Neurofilament light chain as a biological marker for amyotrophic lateral sclerosis: a meta-analysis study. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 23:5-6, pages 446-457.
Read now
Read now
Ulf Kläppe, Sanharib Chamoun, Qing Shen, Anja Finn, Björn Evertsson, Henrik Zetterberg, Kaj Blennow, Rayomand Press, Kristin Samuelsson, Anna Månberg, Fang Fang & Caroline Ingre. (2022) Cardiac troponin T is elevated and increases longitudinally in ALS patients. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 23:1-2, pages 58-65.
Read now
Read now
Caterina Bendotti, Valentina Bonetto, Elisabetta Pupillo, Giancarlo Logroscino, Ammar Al-Chalabi, Christian Lunetta, Nilo Riva, Gabriela Mora, Giuseppe Lauria, Jochen H. Weishaupt, Federica Agosta, Andrea Malaspina, Manuela Basso, Linda Greensmith, Ludo Van Den Bosch, Antonia Ratti, Massimo Corbo, Orla Hardiman, Adriano Chiò, Vincenzo Silani & Ettore Beghi. (2020) Focus on the heterogeneity of amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 21:7-8, pages 485-495.
Read now
Read now
Erin N. Smith, Jonghun Lee, Daria Prilutsky, Stephen Zicha, Zemin Wang, Steve Han & Neta Zach. Plasma neurofilament light levels show elevation two years prior to diagnosis of amyotrophic lateral sclerosis in the UK Biobank. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 0:0, pages 1-7.
Read now
Read now
Articles from other publishers (57)
Agathe Vrillon, Nicholas J. Ashton, Thomas K. Karikari, Karl Götze, Emmanuel Cognat, Julien Dumurgier, Matthieu Lilamand, Henrik Zetterberg, Kaj Blennow & Claire Paquet. (2023) Comparison of CSF and plasma NfL and pNfH for Alzheimer’s disease diagnosis: a memory clinic study. Journal of Neurology.
Crossref
Crossref
Stefano Salvioli, Maria Sofia Basile, Leonardo Bencivenga, Sara Carrino, Maria Conte, Sarah Damanti, Rebecca De Lorenzo, Eleonora Fiorenzato, Alessandro Gialluisi, Assunta Ingannato, Angelo Antonini, Nicola Baldini, Miriam Capri, Simone Cenci, Licia Iacoviello, Benedetta Nacmias, Fabiola Olivieri, Giuseppe Rengo, Patrizia Rovere Querini & Fabrizia Lattanzio. (2023) Biomarkers of aging in frailty and age-associated disorders: State of the art and future perspective. Ageing Research Reviews 91, pages 102044.
Crossref
Crossref
Luisa Donini, Raffaella Tanel, Riccardo Zuccarino & Manuela Basso. (2023) Protein biomarkers for the diagnosis and prognosis of Amyotrophic Lateral Sclerosis. Neuroscience Research.
Crossref
Crossref
Michael Benatar, Martin R. Turner & Joanne Wuu. (2023) Presymptomatic amyotrophic lateral sclerosis: from characterization to prevention. Current Opinion in Neurology 36:4, pages 360-364.
Crossref
Crossref
Michael Benatar, Joanne Wuu & Martin R Turner. (2023) Neurofilament light chain in drug development for amyotrophic lateral sclerosis: a critical appraisal. Brain 146:7, pages 2711-2716.
Crossref
Crossref
Alexander G Thompson, Rachael Marsden, Kevin Talbot & Martin R Turner. (2023) Primary care blood tests show lipid profile changes in pre-symptomatic amyotrophic lateral sclerosis. Brain Communications 5:4.
Crossref
Crossref
Laura Tzeplaeff, Sibylle Wilfling, Maria Viktoria Requardt & Meret Herdick. (2023) Current State and Future Directions in the Therapy of ALS. Cells 12:11, pages 1523.
Crossref
Crossref
Fabiola De Marchi, Toni Franjkic, Paride Schito, Tommaso Russo, Jerneja Nimac, Anna A. Chami, Angelica Mele, Lea Vidatic, Jasna Kriz, Jean-Pierre Julien, Gordana Apic, Robert B. Russell, Boris Rogelj, Jason R. Cannon, Marco Baralle, Federica Agosta, Silva Hecimovic, Letizia Mazzini, Emanuele Buratti & Ivana Munitic. (2023) Emerging Trends in the Field of Inflammation and Proteinopathy in ALS/FTD Spectrum Disorder. Biomedicines 11:6, pages 1599.
Crossref
Crossref
Michael Benatar, Stephen A Goutman, Kim A Staats, Eva L Feldman, Marc Weisskopf, Evelyn Talbott, Kuldip D Dave, Neil M Thakur & Ammar Al-Chalabi. (2023) A roadmap to ALS prevention: strategies and priorities. Journal of Neurology, Neurosurgery & Psychiatry 94:5, pages 399-402.
Crossref
Crossref
Daniel Sanchez-Tejerina, Arnau Llaurado, Javier Sotoca, Veronica Lopez-Diego, Jose M. Vidal Taboada, Maria Salvado & Raul Juntas-Morales. (2023) Biofluid Biomarkers in the Prognosis of Amyotrophic Lateral Sclerosis: Recent Developments and Therapeutic Applications. Cells 12:8, pages 1180.
Crossref
Crossref
Maximilian Vidovic, Lars Hendrik Müschen, Svenja Brakemeier, Gerrit Machetanz, Marcel Naumann & Sergio Castro-Gomez. (2023) Current State and Future Directions in the Diagnosis of Amyotrophic Lateral Sclerosis. Cells 12:5, pages 736.
Crossref
Crossref
Omair Adil & Mohtashim H. Shamsi. (2023) Electrochemical Impedance Immunoassay for ALS-Associated Neurofilament Protein: Matrix Effect on the Immunoplatform. Biosensors 13:2, pages 247.
Crossref
Crossref
Maxim De Schaepdryver, Pegah Masrori, Philip Van Damme & Koen Poesen. (2022) Effect of neurofilament analysis on the diagnostic delay in amyotrophic lateral sclerosis. CNS Neuroscience & Therapeutics 29:1, pages 70-77.
Crossref
Crossref
David S. Younger. 2023. Motor System Disorders, Part I: Normal Physiology and Function and Neuromuscular Disorders. Motor System Disorders, Part I: Normal Physiology and Function and Neuromuscular Disorders
183
250
.
David S. Younger & Robert H. BrownJr.Jr.. 2023. Motor System Disorders, Part II: Spinal Cord, Neurodegenerative, and Cerebral Disorders and Treatment. Motor System Disorders, Part II: Spinal Cord, Neurodegenerative, and Cerebral Disorders and Treatment
203
229
.
Axel Petzold. (2022) The 2022 Lady Estelle Wolfson lectureship on neurofilaments. Journal of Neurochemistry 163:3, pages 179-219.
Crossref
Crossref
Michael Benatar, Volkan Granit, Peter M Andersen, Anne-Laure Grignon, Caroline McHutchison, Stephanie Cosentino, Andrea Malaspina & Joanne Wuu. (2022) Mild motor impairment as prodromal state in amyotrophic lateral sclerosis: a new diagnostic entity. Brain 145:10, pages 3500-3508.
Crossref
Crossref
Ellie Sturmey & Andrea Malaspina. (2022)
Blood biomarkers in
ALS
: challenges, applications and novel frontiers
. Acta Neurologica Scandinavica 146:4, pages 375-388.
Crossref
Crossref
Gloria Mak, Suresh Menon & Jian-Qiang Lu. (2022) Neurofilaments in neurologic disorders and beyond. Journal of the Neurological Sciences 441, pages 120380.
Crossref
Crossref
Frances Theunissen, Ryan S. Anderton, Frank L. Mastaglia, Ian James, Richard Bedlack & P. Anthony Akkari. (2022) Intronic NEFH variant is associated with reduced risk for sporadic ALS and later age of disease onset. Scientific Reports 12:1.
Crossref
Crossref
Hiroshi Mitsumoto, Edward J. Kasarskis & Zachary Simmons. (2022) Hastening the Diagnosis of Amyotrophic Lateral Sclerosis. Neurology 99:2, pages 60-68.
Crossref
Crossref
Christina N. Fournier. (2022) Considerations for Amyotrophic Lateral Sclerosis (ALS) Clinical Trial Design. Neurotherapeutics 19:4, pages 1180-1192.
Crossref
Crossref
Michael Benatar, Joanne Wuu, Peter M. Andersen, Robert C. Bucelli, Jinsy A. Andrews, Markus Otto, Nita A. Farahany, Elizabeth A. Harrington, Weiping Chen, Adele A. Mitchell, Toby Ferguson, Sheena Chew, Liz Gedney, Sue Oakley, Jeong Heo, Sowmya Chary, Laura Fanning, Danielle Graham, Peng Sun, Yingying Liu, Janice Wong & Stephanie Fradette. (2022) Design of a Randomized, Placebo-Controlled, Phase 3 Trial of Tofersen Initiated in Clinically Presymptomatic SOD1 Variant Carriers: the ATLAS Study. Neurotherapeutics 19:4, pages 1248-1258.
Crossref
Crossref
Ton Fang, Goun Je, Peter Pacut, Kiandokht Keyhanian, Jeff Gao & Mehdi Ghasemi. (2022) Gene Therapy in Amyotrophic Lateral Sclerosis. Cells 11:13, pages 2066.
Crossref
Crossref
Jared S. Katzeff, Fiona Bright, Katherine Phan, Jillian J. Kril, Lars M. Ittner, Michael Kassiou, John R. Hodges, Olivier Piguet, Matthew C. Kiernan, Glenda M. Halliday & Woojin Scott Kim. (2022) Biomarker discovery and development for frontotemporal dementia and amyotrophic lateral sclerosis. Brain 145:5, pages 1598-1609.
Crossref
Crossref
Emma L van der Ende, Esther E Bron, Jackie M Poos, Lize C Jiskoot, Jessica L Panman, Janne M Papma, Lieke H Meeter, Elise G P Dopper, Carlo Wilke, Matthis Synofzik, Carolin Heller, Imogen J Swift, Aitana Sogorb-Esteve, Arabella Bouzigues, Barbara Borroni, Raquel Sanchez-Valle, Fermin Moreno, Caroline Graff, Robert LaforceJrJr, Daniela Galimberti, Mario Masellis, Maria Carmela Tartaglia, Elizabeth Finger, Rik Vandenberghe, James B Rowe, Alexandre de Mendonça, Fabrizio Tagliavini, Isabel Santana, Simon Ducharme, Christopher R Butler, Alexander Gerhard, Johannes Levin, Adrian Danek, Markus Otto, Yolande A L Pijnenburg, Sandro Sorbi, Henrik Zetterberg, Wiro J Niessen, Jonathan D Rohrer, Stefan Klein, John C van Swieten, Vikram Venkatraghavan, Harro Seelaar, Sónia Afonso, Maria Rosario Almeida, Sarah Anderl-Straub, Christin Andersson, Anna Antonell, Silvana Archetti, Andrea Arighi, Mircea Balasa, Myriam Barandiaran, Nuria Bargalló, Robart Bartha, Benjamin Bender, Alberto Benussi, Luisa Benussi, Valentina Bessi, Giuliano Binetti, Sandra Black, Martina Bocchetta, Sergi Borrego-Ecija, Jose Bras, Rose Bruffaerts, Marta Cañada, Valentina Cantoni, Paola Caroppo, David Cash, Miguel Castelo-Branco, Rhian Convery, Thomas Cope, Giuseppe Di Fede, Alina Díez, Diana Duro, Chiara Fenoglio, Camilla Ferrari, Catarina B Ferreira, Nick Fox, Morris Freedman, Giorgio Fumagalli, Alazne Gabilondo, Roberto Gasparotti, Serge Gauthier, Stefano Gazzina, Giorgio Giaccone, Ana Gorostidi, Caroline Greaves, Rita Guerreiro, Tobias Hoegen, Begoña Indakoetxea, Vesna Jelic, Hans-Otto Karnath, Ron Keren, Tobias Langheinrich, Maria João Leitão, Albert Lladó, Gemma Lombardi, Sandra Loosli, Carolina Maruta, Simon Mead, Gabriel Miltenberger, Rick van Minkelen, Sara Mitchell, Katrina Moore, Benedetta Nacmias, Jennifer Nicholas, Linn Öijerstedt, Jaume Olives, Sebastien Ourselin, Alessandro Padovani, Georgia Peakman, Michela Pievani, Yolande Pijnenburg, Cristina Polito, Enrico Premi, Sara Prioni, Catharina Prix, Rosa Rademakers, Veronica Redaelli, Tim Rittman, Ekaterina Rogaeva, Pedro Rosa-Neto, Giacomina Rossi, Martin Rosser, Beatriz Santiago, Elio Scarpini, Sonja Schönecker, Elisa Semler, Rachelle Shafei, Christen Shoesmith, Miguel Tábuas-Pereira, Mikel Tainta, Ricardo Taipa, David Tang-Wai, David L Thomas, Paul Thompson, Hakan Thonberg, Carolyn Timberlake, Pietro Tiraboschi, Emily Todd, Philip Van Damme, Mathieu Vandenbulcke, Michele Veldsman, Ana Verdelho, Jorge Villanua, Jason Warren, Ione Woollacott, Elisabeth Wlasich & Miren Zulaica. (2022) A data-driven disease progression model of fluid biomarkers in genetic frontotemporal dementia. Brain 145:5, pages 1805-1817.
Crossref
Crossref
D. Saracino & I. Le Ber. (2022) How can we define the presymptomatic C9orf72 disease in 2022? An overview on the current definitions of preclinical and prodromal phases. Revue Neurologique 178:5, pages 426-436.
Crossref
Crossref
Marie Dreger, Robert Steinbach, Markus Otto, Martin R Turner & Julian Grosskreutz. (2022) Cerebrospinal fluid biomarkers of disease activity and progression in amyotrophic lateral sclerosis. Journal of Neurology, Neurosurgery & Psychiatry 93:4, pages 422-435.
Crossref
Crossref
Michael Benatar, Joanne Wuu, Caroline McHutchison, Ronald B Postuma, Bradley F Boeve, Ronald Petersen, Christopher A Ross, Howard Rosen, Jalayne J Arias, Stephanie Fradette, Michael P McDermott, Jeremy Shefner, Christine Stanislaw, Sharon Abrahams, Stephanie Cosentino, Peter M Andersen, Richard S Finkel, Volkan Granit, Anne-Laure Grignon, Jonathan D Rohrer, Corey T McMillan, Murray Grossman, Ammar Al-Chalabi, Martin R Turner, Ammar Al-Chalabi, Peter M Andersen, Jalayne Arias, Michael Benatar, Bradley Boeve, Stephanie Cosentino, Kuldip Dave, Toby Ferguson, Mary-Kay Floeter, Jonathan Rohrer, Stephanie Fradette, Tania Gendron, Volkan Granit, Anne-Laure Grignon, Murray Grossman, Amelie Gubitz, Petra Kaufman, Isabelle Le Ber, Suzee Lee, Andrea Malaspina, Michael P McDermott, Caroline McHutchison, Corey McMillan, Katie Nicholson, Ronald Petersen, Ronald Postuma, Richard Robinson, Howard Rosen, Christopher Ross, Jeremy Shefner, Christine Stanislaw, Nadine Tatton, Neil Thakur, Martin Turner, Jochen Weishaupt & Joanne Wuu. (2022) Preventing amyotrophic lateral sclerosis: insights from pre-symptomatic neurodegenerative diseases. Brain 145:1, pages 27-44.
Crossref
Crossref
Ozlem Yildiz, Johannes Schroth, Vittoria Lombardi, Valentina Pucino, Yoana Bobeva, Ping Yip, Klaus Schmierer, Claudio Mauro, Timothy Tree, Sian Henson & Andrea Malaspina. (2022) The Expression of Active CD11b Monocytes in Blood and Disease Progression in Amyotrophic Lateral Sclerosis. International Journal of Molecular Sciences 23:6, pages 3370.
Crossref
Crossref
Shotaro Haji, Wataru Sako, Nagahisa Murakami, Yusuke Osaki & Yuishin Izumi. (2022) Serum NfL and CHI3L1 for ALS and parkinsonian disorders in the process of diagnosis. Journal of Neural Transmission 129:3, pages 301-309.
Crossref
Crossref
Jean Escal, Anthony Fourier, Maité Formaglio, Luc Zimmer, Emilien Bernard, Hélène Mollion, Muriel Bost, Mathieu Herrmann, Elisabeth Ollagnon-Roman, Isabelle Quadrio & Jean-Michel Dorey. (2021) Comparative diagnosis interest of NfL and pNfH in CSF and plasma in a context of FTD–ALS spectrum. Journal of Neurology 269:3, pages 1522-1529.
Crossref
Crossref
Giorgia Querin, Maria Grazia Biferi & Pierre-Francois Pradat. (2022) Biomarkers for C9orf7-ALS in Symptomatic and Pre-symptomatic Patients: State-of-the-art in the New Era of Clinical Trials. Journal of Neuromuscular Diseases 9:1, pages 25-37.
Crossref
Crossref
Cory J. Holdom, Frederik J. Steyn, Robert D. Henderson, Pamela A. McCombe, Mary-Louise Rogers & Shyuan T. Ngo. 2022. Neurodegenerative Diseases Biomarkers. Neurodegenerative Diseases Biomarkers
263
306
.
Laura Pasetto, Stefano Callegaro, Alessandro Corbelli, Fabio Fiordaliso, Deborah Ferrara, Laura Brunelli, Giovanna Sestito, Roberta Pastorelli, Elisa Bianchi, Marina Cretich, Marcella Chiari, Cristina Potrich, Cristina Moglia, Massimo Corbo, Gianni Sorarù, Christian Lunetta, Andrea Calvo, Adriano Chiò, Gabriele Mora, Maria Pennuto, Alessandro Quattrone, Francesco Rinaldi, Vito Giuseppe D’Agostino, Manuela Basso & Valentina Bonetto. (2021) Decoding distinctive features of plasma extracellular vesicles in amyotrophic lateral sclerosis. Molecular Neurodegeneration 16:1.
Crossref
Crossref
Dario Saracino, Karim Dorgham, Agnès Camuzat, Daisy Rinaldi, Armelle Rametti-Lacroux, Marion Houot, Fabienne Clot, Philippe Martin-Hardy, Ludmila Jornea, Carole Azuar, Raffaella Migliaccio, Florence Pasquier, Philippe Couratier, Sophie Auriacombe, Mathilde Sauvée, Claire Boutoleau-Bretonnière, Jérémie Pariente, Mira Didic, Didier Hannequin, David Wallon, Olivier Colliot, Bruno Dubois, Alexis Brice, Richard Levy, Sylvie Forlani & Isabelle Le Ber. (2021)
Plasma NfL levels and longitudinal change rates in
C9orf72
and
GRN
-associated diseases: from tailored references to clinical applications
. Journal of Neurology, Neurosurgery & Psychiatry 92:12, pages 1278-1288.
Crossref
Crossref
Rangariroyashe H. Chipika, We Fong Siah, Mary Clare McKenna, Stacey Li Hi Shing, Orla Hardiman & Peter Bede. (2020) The presymptomatic phase of amyotrophic lateral sclerosis: are we merely scratching the surface?. Journal of Neurology 268:12, pages 4607-4629.
Crossref
Crossref
Kjetil Bjornevik, Eilis J. O'ReillySamantha MolsberryLaurence N. KolonelLoic Le MarchandSabrina PaganoniMichael A. SchwarzschildPascal Benkert, Jens KuhleAlberto Ascherio. (2021) Prediagnostic Neurofilament Light Chain Levels in Amyotrophic Lateral Sclerosis. Neurology 97:15.
Crossref
Crossref
Aidong Yuan & Ralph A. Nixon. (2021) Neurofilament Proteins as Biomarkers to Monitor Neurological Diseases and the Efficacy of Therapies. Frontiers in Neuroscience 15.
Crossref
Crossref
Andrea Barp, Amanda Ferrero, Silvia Casagrande, Roberta Morini & Riccardo Zuccarino. (2021) Circulating Biomarkers in Neuromuscular Disorders: What Is Known, What Is New. Biomolecules 11:8, pages 1246.
Crossref
Crossref
James BerryBenjamin Brooks, Angela GengeTerry Heiman-PattersonStanley AppelMichael BenatarRobert BowserMerit CudkowiczClifton GoochJeremy ShefnerJurjen WestraWendy AgneseCharlotte MerrillSally NelsonStephen Apple. (2021) Radicava/Edaravone Findings in Biomarkers From Amyotrophic Lateral Sclerosis (REFINE-ALS). Neurology Clinical Practice 11:4.
Crossref
Crossref
Pamela M. Rist, Varant Kupelian, Marco Petrillo, Jihee Sohn, Wildon Farwell & Howard D. Sesso. (2021) 14-Year Changes in Plasma Neurofilament Levels Among Men: A Pilot Study. Journal of Neuromuscular Diseases 8:4, pages 621-624.
Crossref
Crossref
Federico Verde, Markus Otto & Vincenzo Silani. (2021) Neurofilament Light Chain as Biomarker for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Frontiers in Neuroscience 15.
Crossref
Crossref
Agnes L. Nishimura & Natalia Arias. (2021) Synaptopathy Mechanisms in ALS Caused by C9orf72 Repeat Expansion. Frontiers in Cellular Neuroscience 15.
Crossref
Crossref
Lorenzo Gaetani, Lucilla Parnetti, Paolo Calabresi & Massimiliano Di Filippo. (2021) Tracing Neurological Diseases in the Presymptomatic Phase: Insights From Neurofilament Light Chain. Frontiers in Neuroscience 15.
Crossref
Crossref
Marie Dreger, Robert Steinbach, Nayana Gaur, Klara Metzner, Beatrice Stubendorff, Otto W. Witte & Julian Grosskreutz. (2021) Cerebrospinal Fluid Neurofilament Light Chain (NfL) Predicts Disease Aggressiveness in Amyotrophic Lateral Sclerosis: An Application of the D50 Disease Progression Model. Frontiers in Neuroscience 15.
Crossref
Crossref
Megan G Pino, Kelly A Rich & Stephen J Kolb. (2021) Update on Biomarkers in Spinal Muscular Atrophy. Biomarker Insights 16, pages 117727192110356.
Crossref
Crossref
Elisabetta Zucchi, Valentina Bonetto, Gianni Sorarù, Ilaria Martinelli, Piero Parchi, Rocco Liguori & Jessica Mandrioli. (2020) Neurofilaments in motor neuron disorders: towards promising diagnostic and prognostic biomarkers. Molecular Neurodegeneration 15:1.
Crossref
Crossref
Christian Barro, Tanuja Chitnis & Howard L. Weiner. (2020) Blood neurofilament light: a critical review of its application to neurologic disease. Annals of Clinical and Translational Neurology 7:12, pages 2508-2523.
Crossref
Crossref
Brit Mollenhauer, Mohammed Dakna, Niels Kruse, Douglas Galasko, Tatiana Foroud, Henrik Zetterberg, Sebastian Schade, Roland G. Gera, Wenting Wang, Feng Gao, Mark Frasier, Lana M. Chahine, Christopher S. Coffey, Andrew B. Singleton, Tanya Simuni, Daniel Weintraub, John Seibyl, Arthur W. Toga, Caroline M. Tanner, Karl Kieburtz, Kenneth Marek, Andrew Siderowf, Jesse M. Cedarbaum, Samantha J. Hutten, Claudia Trenkwalder & Danielle Graham. (2020) Validation of Serum Neurofilament Light Chain as a Biomarker of Parkinson's Disease Progression. Movement Disorders 35:11, pages 1999-2008.
Crossref
Crossref
Allyson L. Mellinger, Emily H. Griffith & Michael S. Bereman. (2020) Peptide variability and signatures associated with disease progression in CSF collected longitudinally from ALS patients. Analytical and Bioanalytical Chemistry 412:22, pages 5465-5475.
Crossref
Crossref
Elizabeth Gray, Alexander G. Thompson, Joanne Wuu, Joe Pelt, Kevin Talbot, Michael Benatar & Martin R. Turner. (2020) CSF chitinases before and after symptom onset in amyotrophic lateral sclerosis. Annals of Clinical and Translational Neurology 7:8, pages 1296-1306.
Crossref
Crossref
Joke De Vocht, Jeroen Blommaert, Martijn Devrome, Ahmed Radwan, Donatienne Van Weehaeghe, Maxim De Schaepdryver, Jenny Ceccarini, Ahmadreza Rezaei, Georg Schramm, June van Aalst, Adriano Chiò, Marco Pagani, Daphne Stam, Hilde Van Esch, Nikita Lamaire, Marianne Verhaegen, Nathalie Mertens, Koen Poesen, Leonard H. van den Berg, Michael A. van Es, Rik Vandenberghe, Mathieu Vandenbulcke, Jan Van den Stock, Michel Koole, Patrick Dupont, Koen Van Laere & Philip Van Damme. (2020)
Use of Multimodal Imaging and Clinical Biomarkers in Presymptomatic Carriers of
C9orf72
Repeat Expansion
. JAMA Neurology 77:8, pages 1008.
Crossref
Crossref
Michael Benatar, Lanyu ZhangLily WangVolkan Granit, Jeffrey Statland, Richard BarohnAndrea SwensonJohn RavitsCarlayne JacksonTed M. BurnsJaya TrivediErik P. Pioro, James Caress, Jonathan KatzJacob L. McCauley, Rosa RademakersAndrea MalaspinaLyle W. OstrowJoanne WuuSumaira Hussain, Anne Cooley, Yindi Li, Marielle Wallace, Julie Steele, Jessica P Hernandez, Jessica Medina, Maria Elena Paredes, Ashley Manso, Natalia Ravelo, Wendy Levy, Patrice Whitehead, Stephan Zuchner, Mamatha Pasnoor, Omar Jawdat, Duaa Jabari, Constantine Farmakidis, Melanie Glenn, Mazen M Dimachkie, Laura Herbelin, Hellen Tanui, Sherri Anderson, Michaela Walker, Tina Liu, Ayla McCally, Andrew Heim, Melissa Currence, Yolanda Harness, Jeri Sieren, Emilee Gibson, Gil Gutierrez, Danielle Bussey, Rose Previte, Pamella Kittrell, Amruta Joshi, Amy Conger, Debbie Hastings, Irys Caristo, Mozhdeh Marandi, Simon Carty, J Paul Taylor, Gang Wu, Evadnie Rampersaud, Rebecca Schule & Marka van Blitterswijk. (2020) Validation of serum neurofilaments as prognostic and potential pharmacodynamic biomarkers for ALS. Neurology 95:1.
Crossref
Crossref
Fen Huang, Yuda Zhu, Jennifer Hsiao‐Nakamoto, Xinyan Tang, Jason C. Dugas, Miriam Moscovitch‐Lopatin, Jonathan D. Glass, Robert H. BrownJrJr, Shafeeq S. Ladha, David Lacomis, Jeffrey M. Harris, Kimberly Scearce‐Levie, Carole Ho, Robert Bowser & James D. Berry. (2020) Longitudinal biomarkers in amyotrophic lateral sclerosis. Annals of Clinical and Translational Neurology 7:7, pages 1103-1116.
Crossref
Crossref
Nicholas J. Ashton, Abdul Hye, Anto P. Rajkumar, Antoine Leuzy, Stuart Snowden, Marc Suárez-Calvet, Thomas K. Karikari, Michael Schöll, Renaud La Joie, Gil D. Rabinovici, Kina Höglund, Clive Ballard, Tibor Hortobágyi, Per Svenningsson, Kaj Blennow, Henrik Zetterberg & Dag Aarsland. (2020) An update on blood-based biomarkers for non-Alzheimer neurodegenerative disorders. Nature Reviews Neurology 16:5, pages 265-284.
Crossref
Crossref
Lucas Vu, Jiyan An, Tina Kovalik, Tania Gendron, Leonard Petrucelli & Robert Bowser. (2020) Cross-sectional and longitudinal measures of chitinase proteins in amyotrophic lateral sclerosis and expression of CHI3L1 in activated astrocytes. Journal of Neurology, Neurosurgery & Psychiatry 91:4, pages 350-358.
Crossref
Crossref